Virginia Picasso

896 total citations
16 papers, 661 citations indexed

About

Virginia Picasso is a scholar working on Oncology, Molecular Biology and Ophthalmology. According to data from OpenAlex, Virginia Picasso has authored 16 papers receiving a total of 661 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 8 papers in Molecular Biology and 5 papers in Ophthalmology. Recurrent topics in Virginia Picasso's work include Melanoma and MAPK Pathways (8 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Immunotherapy and Immune Responses (4 papers). Virginia Picasso is often cited by papers focused on Melanoma and MAPK Pathways (8 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Immunotherapy and Immune Responses (4 papers). Virginia Picasso collaborates with scholars based in Italy, United Kingdom and Switzerland. Virginia Picasso's co-authors include Paola Queirolo, Francesco Spagnolo, L. Orgiano, Elena Tornari, Paola Ghiorzo, Lorenza Pastorino, Lorenza Di Guardo, Francesco De Rosa, Simone Ribero and Luigia Stefania Stucci and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Oncology.

In The Last Decade

Virginia Picasso

15 papers receiving 653 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Virginia Picasso Italy 12 400 314 197 157 101 16 661
Michael Fluck Germany 11 501 1.3× 379 1.2× 223 1.1× 186 1.2× 173 1.7× 24 770
Elisa Funck‐Brentano France 14 377 0.9× 213 0.7× 219 1.1× 39 0.2× 73 0.7× 36 752
Christine Longvert France 12 353 0.9× 233 0.7× 106 0.5× 43 0.3× 59 0.6× 34 525
Anette Weber Germany 14 490 1.2× 370 1.2× 77 0.4× 68 0.4× 87 0.9× 18 882
Elena Tornari Italy 9 244 0.6× 161 0.5× 108 0.5× 32 0.2× 71 0.7× 12 431
Hojabr Kakavand Australia 15 1.1k 2.8× 501 1.6× 583 3.0× 78 0.5× 179 1.8× 20 1.4k
L. Orgiano Italy 8 226 0.6× 180 0.6× 108 0.5× 32 0.2× 34 0.3× 13 382
Florentia Dimitriou Switzerland 16 665 1.7× 250 0.8× 230 1.2× 27 0.2× 150 1.5× 50 936
Viviana Bozón United States 11 525 1.3× 195 0.6× 377 1.9× 19 0.1× 58 0.6× 28 662
Jasmine I. Rizzo United States 8 1.1k 2.7× 382 1.2× 465 2.4× 28 0.2× 239 2.4× 18 1.3k

Countries citing papers authored by Virginia Picasso

Since Specialization
Citations

This map shows the geographic impact of Virginia Picasso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Virginia Picasso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Virginia Picasso more than expected).

Fields of papers citing papers by Virginia Picasso

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Virginia Picasso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Virginia Picasso. The network helps show where Virginia Picasso may publish in the future.

Co-authorship network of co-authors of Virginia Picasso

This figure shows the co-authorship network connecting the top 25 collaborators of Virginia Picasso. A scholar is included among the top collaborators of Virginia Picasso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Virginia Picasso. Virginia Picasso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Pesce, Marianna, Elena Tornari, Virginia Picasso, et al.. (2026). SOLAR RADIATION AS A RISK FACTOR FOR CUTANEOUS MELANOMA: REVIEW. SHILAP Revista de lepidopterología. 8.
2.
Picasso, Riccardo, et al.. (2023). Immune checkpoint inhibitor-related pneumonitis and COVID-19: a case-matched comparison of CT findings. La radiologia medica. 128(2). 212–221. 4 indexed citations
3.
Ribero, Simone, Luigia Stefania Stucci, Riccardo Marconcini, et al.. (2018). Effect of Age on Melanoma Risk, Prognosis and Treatment Response. Acta Dermato Venereologica. 98(7). 624–629. 61 indexed citations
4.
Stucci, Luigia Stefania, Stella D’Oronzo, Marco Tucci, et al.. (2018). Vitamin D in melanoma: Controversies and potential role in combination with immune check-point inhibitors. Cancer Treatment Reviews. 69. 21–28. 32 indexed citations
5.
Marconcini, Riccardo, Francesco Spagnolo, Luigia Stefania Stucci, et al.. (2017). Current status and perspectives in immunotherapy for metastatic melanoma. Oncotarget. 9(15). 12452–12470. 69 indexed citations
6.
Inno, Alessandro, Giulio Metro, Paolo Bironzo, et al.. (2017). Pathogenesis, Clinical Manifestations and Management of Immune Checkpoint Inhibitors Toxicity. Tumori Journal. 103(5). 405–421. 52 indexed citations
7.
8.
Spagnolo, Francesco, et al.. (2016). Update on Metastatic Uveal Melanoma: Progress and Challenges. BioDrugs. 30(3). 161–172. 13 indexed citations
9.
Queirolo, Paola, Francesco Spagnolo, Virginia Picasso, et al.. (2016). Combined vemurafenib and fotemustine in patients with BRAF V600 melanoma progressing on vemurafenib. Oncotarget. 9(15). 12408–12417. 11 indexed citations
10.
Spagnolo, Francesco, Paola Ghiorzo, L. Orgiano, et al.. (2015). BRAF-mutant melanoma: treatment approaches, resistance mechanisms, and diagnostic strategies. OncoTargets and Therapy. 8. 157–157. 117 indexed citations
11.
Queirolo, Paola, Virginia Picasso, & Francesco Spagnolo. (2015). Combined BRAF and MEK inhibition for the treatment of BRAF-mutated metastatic melanoma. Cancer Treatment Reviews. 41(6). 519–526. 57 indexed citations
12.
13.
Barisione, Gaia, Marina Fabbi, Paola Queirolo, et al.. (2015). Potential Role of Soluble c-Met as a New Candidate Biomarker of Metastatic Uveal Melanoma. JAMA Ophthalmology. 133(9). 1013–1013. 45 indexed citations
14.
Queirolo, Paola, Francesco Spagnolo, Virginia Picasso, et al.. (2014). BeyPro1: A phase II single-arm study for the treatment after recurrence of advanced melanoma patients harboring the V600BRAF mutation and pretreated with vemurafenib, with the association of vemurafenib plus fotemustine.. Journal of Clinical Oncology. 32(15_suppl). TPS9109–TPS9109. 2 indexed citations
15.
Maio, Michele, Riccardo Danielli, Vanna Chiarion‐Sileni, et al.. (2013). Efficacy and safety of ipilimumab in patients with pre-treated, uveal melanoma. Annals of Oncology. 24(11). 2911–2915. 109 indexed citations
16.
Spagnolo, Francesco, Marco Grosso, Virginia Picasso, et al.. (2013). Treatment of metastatic uveal melanoma with intravenous fotemustine. Melanoma Research. 23(3). 196–198. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael Fluck Breakdown of academic impact, for papers by Elisa Funck‐Brentano Breakdown of academic impact, for papers by Christine Longvert Breakdown of academic impact, for papers by Anette Weber Breakdown of academic impact, for papers by Elena Tornari Breakdown of academic impact, for papers by Hojabr Kakavand Breakdown of academic impact, for papers by L. Orgiano Breakdown of academic impact, for papers by Florentia Dimitriou Breakdown of academic impact, for papers by Viviana Bozón Breakdown of academic impact, for papers by Jasmine I. Rizzo
Rankless by CCL
2026